Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.

Pharmacogenomics - 1 Nov 2017

Martin Antony, Downing Jennifer, Maden Michelle, Fleeman Nigel, Alfirevic Ana, Haycox Alan, Pirmohamed Munir

Abstract excerpt

This review assessed evidence of disparities in benefits of pharmacogenomics related to 'model performance' in subgroups of patients and studies which reported impact on health inequalities. 'Model performance' refers to the ability of algorithms including clinical, environmental and genetic information to guide treatment. A total of 4978 abstracts were screened by one reviewer and 30% (1494) were double screened...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Delivery of Health Care
Share to Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Healthcare Disparities

Share to Pharmacogenetics

Share to Socioeconomic Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 29095091
DOI: 10.2217/pgs-2017-0076
PMCID: PMC5694021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.PMID 29095091Read ↗

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response OutcomesSemantic proximity Read ↗

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes.Semantic proximity Read ↗

Integrating pharmacogenetics into society: in search of a modelSemantic proximity Read ↗

Implementing a Pharmacogenomic-driven Algorithm to Guide Antiplatelet Therapy among Caribbean Hispanics: A non-randomized prospective cohort studySemantic proximity Read ↗

Comparative performance of gene-based warfarin dosing algorithms in a multiethnic populationSemantic proximity Read ↗

Warfarin Pharmacogenomics in Diverse Populations.Semantic proximity Read ↗

Pharmacoeconomic evaluation of warfarin pharmacogenomics.Semantic proximity Read ↗

STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.Semantic proximity Read ↗

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.Semantic proximity Read ↗

Warfarin Pharmacogenetics Reevaluated: Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.Semantic proximity Read ↗

Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Semantic proximity Read ↗

The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.